
POWERFILL
1000 mg/vial PDLLA product presentation. Intended use, preparation and protocol must be confirmed from current official documentation.
Two professional PDLLA product presentations by REGEN Biotech. Country-specific intended use, protocol and regulatory status must be confirmed from current official documentation.

AestheFill and PowerFill are presented for qualified professional review. Final product selection, intended use, preparation, protocol and patient suitability must follow current official documentation and local requirements.

1000 mg/vial PDLLA product presentation. Intended use, preparation and protocol must be confirmed from current official documentation.

200 mg/vial PDLLA product presentation for qualified professional review. Country-specific information must be verified before use.
Contact Dermal Magic LTD for current product information, documentation status and commercial availability.